Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$11.18 - $15.46 $45,838 - $63,386
-4,100 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$14.21 - $17.65 $781 - $970
55 Added 1.36%
4,100 $58,000
Q2 2021

Aug 12, 2021

BUY
$9.5 - $17.24 $427 - $775
45 Added 1.13%
4,045 $63,000
Q1 2021

May 13, 2021

SELL
$7.37 - $13.61 $884 - $1,633
-120 Reduced 2.91%
4,000 $40,000
Q4 2020

Feb 12, 2021

BUY
$3.37 - $8.61 $8,809 - $22,506
2,614 Added 173.57%
4,120 $30,000
Q3 2020

Nov 13, 2020

BUY
$3.43 - $5.53 $5,165 - $8,328
1,506 New
1,506 $5,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.57B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.